Rakuten Securities
PRAX icon

Rakuten Securities’s Praxis Precision Medicines PRAX Stock Holding History

Rakuten Securities’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-3
Closed -$1K – 997
2026
Q2 		$1K Sell
3
-22
-88% -$6.96K ﹤0.01% 724
2026
Q1 		$8.06K Buy
+25
New +$7.73K ﹤0.01% 455

Other funds holding PRAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Rakuten Securities's PRAX Position: Q3 2026 in Review

Rakuten Securities sold out of Praxis Precision Medicines (PRAX) in Q3 2026, closing a stake of 3 shares — an estimated $1K sold.

Rakuten Securities first reported a position in PRAX in Q1 2026 and held it in 2 quarters. The position peaked at $8.06K in Q1 2026. 190 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Rakuten Securities reported no remaining Praxis Precision Medicines position as of Q3 2026 after selling out during the quarter.
  • Rakuten Securities sold 3 Praxis Precision Medicines shares in Q3 2026, an estimated $1K.
  • Rakuten Securities first reported a position in Praxis Precision Medicines in Q1 2026 and held it in 2 quarters.
  • Rakuten Securities's Praxis Precision Medicines position peaked at $8.06K in Q1 2026.
  • 190 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Rakuten Securities's 13F filing for Q3 2026, filed 2 Nov 2026.